Amylyx Pharmaceuticals, Inc. (AMLX)
31.62
-0.47
(-1.46%)
USD |
NASDAQ |
Sep 11, 16:00
31.43
-0.19
(-0.60%)
After-Hours: 06:39
Amylyx Pharmaceuticals Market Cap : 3.521B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.521B |
| September 10, 2026 | 3.574B |
| September 09, 2026 | 3.608B |
| September 08, 2026 | 3.773B |
| September 04, 2026 | 3.798B |
| September 03, 2026 | 3.782B |
| September 02, 2026 | 3.841B |
| September 01, 2026 | 3.765B |
| August 31, 2026 | 3.759B |
| August 28, 2026 | 3.869B |
| August 27, 2026 | 4.141B |
| August 26, 2026 | 4.130B |
| August 25, 2026 | 4.172B |
| August 24, 2026 | 4.249B |
| August 21, 2026 | 4.305B |
| August 20, 2026 | 4.417B |
| August 19, 2026 | 4.299B |
| August 18, 2026 | 3.910B |
| August 17, 2026 | 2.387B |
| August 14, 2026 | 2.409B |
| August 13, 2026 | 2.504B |
| August 12, 2026 | 2.600B |
| August 11, 2026 | 2.632B |
| August 10, 2026 | 2.525B |
| August 07, 2026 | 2.541B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.694B |
| August 05, 2026 | 2.433B |
| August 04, 2026 | 2.436B |
| August 03, 2026 | 2.239B |
| July 31, 2026 | 2.255B |
| July 30, 2026 | 2.304B |
| July 29, 2026 | 2.191B |
| July 28, 2026 | 2.171B |
| July 27, 2026 | 2.164B |
| July 24, 2026 | 2.044B |
| July 23, 2026 | 1.953B |
| July 22, 2026 | 1.965B |
| July 21, 2026 | 2.054B |
| July 20, 2026 | 1.937B |
| July 17, 2026 | 1.971B |
| July 16, 2026 | 1.890B |
| July 15, 2026 | 1.974B |
| July 14, 2026 | 2.021B |
| July 13, 2026 | 1.933B |
| July 10, 2026 | 1.973B |
| July 09, 2026 | 2.041B |
| July 08, 2026 | 1.985B |
| July 07, 2026 | 2.017B |
| July 06, 2026 | 1.995B |
| July 02, 2026 | 2.028B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 157.98B |
| Eli Lilly & Co. | 1.050T |
| Merck & Co., Inc. | 355.31B |
| EyePoint, Inc. | 359.47M |
| Bristol Myers Squibb Co. | 130.02B |
Market Cap Related Metrics
| Price to Book Value | 14.72 |
| Price | 31.62 |
| Earnings Yield | -4.53% |